
90%. $470.6 billion. $5.20. The generic drug math is hard to ignore. New from PCMA’s Head of Research, Amanda Frost, PhD: How generic competition and PBMs work together to drive down drug costs and deliver savings for patients. Read more: pcmanet.org/pcma-blog/specia…









